Implanet S.A [ALIMP] vs Eurobio Scientific [ALERS] Detailed Stock Comparison
Implanet S.A
Euronext
Loading...
Eurobio Scientific
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Implanet S.A wins in 4 metrics, Eurobio Scientific wins in 11 metrics, with 0 ties. Eurobio Scientific appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Implanet S.A | Eurobio Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -10.92 | 65.51 | Implanet S.A |
| Price-to-Book Ratio | N/A | 1.43 | N/A |
| Debt-to-Equity Ratio | -4.49 | 0.19 | Implanet S.A |
| EV/EBITDA | -12.96 | 9.33 | Implanet S.A |
| Profit Margin (TTM) | -43.35% | 1.47% | Eurobio Scientific |
| Operating Margin (TTM) | -36.86% | 7.14% | Eurobio Scientific |
| EBITDA Margin (TTM) | N/A | 7.14% | N/A |
| Return on Equity | -450.05% | 2.24% | Eurobio Scientific |
| Return on Assets (TTM) | -19.48% | 1.55% | Eurobio Scientific |
| Free Cash Flow (TTM) | $-3.04M | $13.45M | Eurobio Scientific |
| 1-Year Return | 241.67% | -1.56% | Implanet S.A |
| Price-to-Sales Ratio (TTM) | 4.95 | 1.58 | Eurobio Scientific |
| Enterprise Value | $60.23M | $269.17M | Eurobio Scientific |
| EV/Revenue Ratio | 5.43 | 1.74 | Eurobio Scientific |
| Revenue per Share (TTM) | $0 | $15 | Eurobio Scientific |
| Earnings per Share (Diluted) | $-0.04 | $0.39 | Eurobio Scientific |
| Beta (Stock Volatility) | 0.97 | 0.36 | Eurobio Scientific |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Implanet S.A vs Eurobio Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Implanet S.A | -6.18% | -2.38% | 41.38% | 310.00% | 310.00% | 241.67% |
| Eurobio Scientific | -1.37% | -0.59% | -0.20% | -0.20% | 8.11% | -0.40% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Implanet S.A | 241.67% | 115.79% | -50.00% | -99.57% | -99.86% | -99.86% |
| Eurobio Scientific | -1.56% | 50.00% | 47.80% | 152.00% | 6.78% | 6.78% |
News Based Sentiment: Implanet S.A vs Eurobio Scientific
Implanet S.A
News sentiment data is not available for Implanet S.A at this time.
Eurobio Scientific
News based Sentiment: POSITIVE
The company reported strong sales growth in its HIV DeepChek® range and secured a key distribution partnership, leading to a positive net result. These developments suggest a positive outlook for the company and its investors.
Performance & Financial Health Analysis: Implanet S.A vs Eurobio Scientific
| Metric | ALIMP | ALERS |
|---|---|---|
| Market Information | ||
| Market Cap | €55.44M | €256.89M |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 624,730 | 799 |
| 90 Day Avg. Volume | 904,078 | 681 |
| Last Close | €0.41 | €25.20 |
| 52 Week Range | €0.08 - €0.45 | €23.20 - €26.50 |
| % from 52W High | -8.89% | -4.91% |
| All-Time High | €336.80 (Feb 17, 2014) | €29.76 (Dec 27, 2021) |
| % from All-Time High | -99.88% | -15.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.41% | 0.11% |
| Quarterly Earnings Growth | N/A | -0.40% |
| Financial Health | ||
| Profit Margin (TTM) | -0.43% | 0.01% |
| Operating Margin (TTM) | -0.37% | 0.07% |
| Return on Equity (TTM) | -4.50% | 0.02% |
| Debt to Equity (MRQ) | -4.49 | 0.19 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-0.01 | €17.82 |
| Cash per Share (MRQ) | €0.00 | N/A |
| Operating Cash Flow (TTM) | €-185,000 | €1.94M |
| Levered Free Cash Flow (TTM) | €537,125 | €4.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Implanet S.A vs Eurobio Scientific
| Metric | ALIMP | ALERS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -10.92 | 65.51 |
| Forward P/E | N/A | 23.02 |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 4.95 | 1.58 |
| Price to Book (MRQ) | N/A | 1.43 |
| Market Capitalization | ||
| Market Capitalization | €55.44M | €256.89M |
| Enterprise Value | €60.23M | €269.17M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.43 | 1.74 |
| Enterprise to EBITDA | -12.96 | 9.33 |
| Risk & Other Metrics | ||
| Beta | 0.97 | 0.36 |
| Book Value per Share (MRQ) | €-0.01 | €17.82 |
Financial Statements Comparison: Implanet S.A vs Eurobio Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALIMP | ALERS |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALIMP | ALERS |
|---|---|---|
| Cash & Equivalents | €1.60M | €21.77M |
| Total Current Assets | €10.32M | €89.59M |
| Total Current Liabilities | €12.21M | €44.15M |
| Long-Term Debt | €1.74M | €31.26M |
| Total Shareholders Equity | €727,000 | €178.86M |
| Retained Earnings | €-4.37M | N/A |
| Property, Plant & Equipment | €4.25M | €11.57M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALIMP | ALERS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALIMP | ALERS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 624,730 | 799 |
| Average Daily Volume (90 Day) | 904,078 | 681 |
| Shares Outstanding | 124.97M | 10.03M |
| Float Shares | 32.26M | 218,750 |
| % Held by Insiders | 0.75% | 0.00% |
| % Held by Institutions | 0.00% | 0.93% |
Dividend Analysis & Yield Comparison: Implanet S.A vs Eurobio Scientific
| Metric | ALIMP | ALERS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |